257 related articles for article (PubMed ID: 5800598)
1. [On the use of antifibrinolytic agents in urology].
Rosdy E; Biró J; Szendröi Z; Szabó V
Acta Chir Acad Sci Hung; 1969; 10(1):25-35. PubMed ID: 5800598
[No Abstract] [Full Text] [Related]
2. [Application of epsilon-aminocaproic acid hydrochloride in hemorrhage in urological patients].
Shemetov VD
Sov Zdravookhr Kirg; 1970; 1():62-4. PubMed ID: 5447557
[No Abstract] [Full Text] [Related]
3. [Clinical significance of the use of antifibrinolytic agents].
Czuczor H; Vecsey D; Bánkuti P
Orv Hetil; 1969 Apr; 110(17):966-9. PubMed ID: 5305356
[No Abstract] [Full Text] [Related]
4. Indications for antifibrinolytic therapy.
Prentice CR
Thromb Diath Haemorrh; 1975 Dec; 34(3):634-43. PubMed ID: 1108280
[No Abstract] [Full Text] [Related]
5. Proteinase inhibitors in urology.
Fürstenberg HS
Acta Chir Scand Suppl; 1967; 378():62-70. PubMed ID: 5300107
[No Abstract] [Full Text] [Related]
6. Antifibrinolytic drugs in the treatment of urinary tract haemorrhage.
Andersson L
Prog Surg; 1972; 10():76-93. PubMed ID: 4670671
[No Abstract] [Full Text] [Related]
7. Control of bleeding during and after prostatectomy.
Fam A
Int Surg; 1971 Nov; 56(5):352-61. PubMed ID: 5315847
[No Abstract] [Full Text] [Related]
8. [Fibrinolysis and loss of blood following prostatic surgery and their susceptibility to antifibrinolyties. Epsilon aminocaproic acid and the kallikrein inhibitor trasylol].
Schmutzler R; Fürstenberg H
Dtsch Med Wochenschr; 1966 Feb; 91(7):297-303. PubMed ID: 5295336
[No Abstract] [Full Text] [Related]
9. [Natural and synthetic protease inhibitors as antifibrinolytic agents. Discussion].
Folia Haematol Int Mag Klin Morphol Blutforsch; 1967; 88(2):244-52. PubMed ID: 4174665
[No Abstract] [Full Text] [Related]
10. [Blood loss in transurethral resection of the prostate].
Madsen PO; Wagenknecht LV; Knuth OE
Urologe; 1970 May; 9(3):122-6. PubMed ID: 5521793
[No Abstract] [Full Text] [Related]
11. [On local treatment of hemorrhages following prostatectomy with antifibrinolytic agents].
Vecsey D; Bánkuti P; Czuczor H
Z Urol Nephrol; 1967 Dec; 60(12):831-5. PubMed ID: 5302248
[No Abstract] [Full Text] [Related]
12. [Reduction of post-prostatectomy bleeding by medication (experience with the antifibrinolytic agent AMCA)].
Kaufmann J; Siefker K
Urologe; 1969; 8(2):57-9. PubMed ID: 5360135
[No Abstract] [Full Text] [Related]
13. [The use of epsilon-aminocaproic acid in urology].
Oberst O
Z Urol Nephrol; 1965; 58(10):717-25. PubMed ID: 5866679
[No Abstract] [Full Text] [Related]
14. [Prevention and therapy of fibrinolytic postoperative bleedings in thoracic surgery].
Wachsmuth W; Viereck HJ
Thoraxchir Vask Chir; 1968 Aug; 16(4):308-14. PubMed ID: 5302180
[No Abstract] [Full Text] [Related]
15. [Antifibrinolytic treatment and forced osmotic diuresis after transurethral prostatectomy].
Lee P; Pompeius R
Nord Med; 1970 Dec; 84(51):1624-6. PubMed ID: 5490738
[No Abstract] [Full Text] [Related]
16. [Coagulation physiological bases of antifibrinolytic treatment in prostatectomies].
Neef H; Preusser KP; Anger G; Richter M
Zentralbl Chir; 1967 Apr; 92(13):486-90. PubMed ID: 5591468
[No Abstract] [Full Text] [Related]
17. [Acute fibrinolysis after prostatectomy].
Aiello D
Sicil Sanit; 1966; 3(1):24-9. PubMed ID: 5296527
[No Abstract] [Full Text] [Related]
18. [Antifibrinolytic therapy in prostatectomies, tonsillectomies and adenotomies].
Ennemoser D; Heidbrink D
Med Welt; 1969 Apr; 17():1028-30. PubMed ID: 5784739
[No Abstract] [Full Text] [Related]
19. [Use of POR 8 in urologic surgery].
Bergmann M
Z Urol Nephrol; 1972 Oct; 65(10):775-9. PubMed ID: 4125081
[No Abstract] [Full Text] [Related]
20. [Effect of sigma-aminocaproic acid on blood coagulation and its fibrinolytic activity in vitro].
Skipetrov VP; Bobrenko GV; Vashchenko TN; Simonova GP
Probl Gematol Pereliv Krovi; 1970 Jun; 15(6):39-42. PubMed ID: 5471517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
